Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Obesity | 8 | 2021 | 7388 | 0.65 | Why? |
| Insulin-Secreting Cells | 1 | 2018 | 273 | 0.60 | Why? |
| Obesity, Morbid | 5 | 2018 | 1340 | 0.40 | Why? |
| Insulin | 1 | 2018 | 1316 | 0.38 | Why? |
| Obesity Management | 2 | 2018 | 31 | 0.36 | Why? |
| Gastric Bypass | 3 | 2018 | 152 | 0.33 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.31 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2011 | 436 | 0.30 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.29 | Why? |
| Body Mass Index | 5 | 2021 | 4306 | 0.27 | Why? |
| Sarcopenia | 2 | 2018 | 422 | 0.24 | Why? |
| Bariatric Surgery | 3 | 2018 | 1298 | 0.24 | Why? |
| Diabetes Mellitus, Type 2 | 4 | 2018 | 6166 | 0.23 | Why? |
| Gastroplasty | 2 | 2018 | 20 | 0.23 | Why? |
| Israel | 5 | 2021 | 2751 | 0.21 | Why? |
| Interleukin-12 | 1 | 2021 | 156 | 0.20 | Why? |
| Interleukin-33 | 1 | 2021 | 120 | 0.20 | Why? |
| Gastrectomy | 2 | 2018 | 225 | 0.19 | Why? |
| Ovum | 1 | 1998 | 35 | 0.19 | Why? |
| Ovarian Diseases | 1 | 1998 | 24 | 0.19 | Why? |
| Triglycerides | 2 | 2018 | 478 | 0.18 | Why? |
| Fertilization in Vitro | 3 | 1998 | 330 | 0.17 | Why? |
| Diet, Reducing | 1 | 2017 | 38 | 0.17 | Why? |
| Intra-Abdominal Fat | 2 | 2017 | 227 | 0.17 | Why? |
| Abdominal Fat | 1 | 2017 | 43 | 0.17 | Why? |
| Dietary Carbohydrates | 1 | 2017 | 64 | 0.17 | Why? |
| Weight Loss | 3 | 2018 | 826 | 0.17 | Why? |
| Dietary Fats | 1 | 2017 | 96 | 0.16 | Why? |
| Suction | 1 | 1998 | 297 | 0.16 | Why? |
| Abscess | 1 | 1998 | 234 | 0.15 | Why? |
| Hyperlipidemias | 1 | 2018 | 290 | 0.15 | Why? |
| Insulin Resistance | 2 | 2018 | 669 | 0.15 | Why? |
| Pericardium | 1 | 2017 | 228 | 0.14 | Why? |
| Adiposity | 4 | 2018 | 329 | 0.14 | Why? |
| Body Weight | 1 | 2020 | 1074 | 0.14 | Why? |
| Internal Medicine | 1 | 2020 | 557 | 0.13 | Why? |
| Advisory Committees | 2 | 2018 | 1418 | 0.13 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.13 | Why? |
| Hospital Departments | 1 | 2020 | 831 | 0.12 | Why? |
| Postoperative Care | 1 | 2018 | 755 | 0.12 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.12 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.12 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.12 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.12 | Why? |
| Critical Care | 3 | 2021 | 14081 | 0.11 | Why? |
| Overweight | 1 | 2018 | 916 | 0.11 | Why? |
| Evidence-Based Practice | 1 | 2017 | 693 | 0.11 | Why? |
| Adamantane | 1 | 2011 | 68 | 0.11 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.11 | Why? |
| Mass Vaccination | 1 | 2021 | 1101 | 0.11 | Why? |
| Risk Factors | 9 | 2020 | 71621 | 0.10 | Why? |
| Dipeptides | 1 | 2011 | 106 | 0.10 | Why? |
| Cardiovascular Diseases | 2 | 2016 | 11497 | 0.10 | Why? |
| Dyslipidemias | 1 | 2017 | 791 | 0.10 | Why? |
| Disease Susceptibility | 2 | 2020 | 4002 | 0.10 | Why? |
| Patient Positioning | 1 | 2021 | 1505 | 0.10 | Why? |
| Laparoscopy | 3 | 2018 | 1532 | 0.10 | Why? |
| National Health Programs | 1 | 2016 | 807 | 0.10 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.10 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2017 | 861 | 0.09 | Why? |
| Blood Glucose | 3 | 2018 | 3642 | 0.09 | Why? |
| Pregnancy in Diabetics | 1 | 1988 | 56 | 0.09 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.09 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Pyrrolidines | 1 | 2011 | 558 | 0.08 | Why? |
| Adult | 15 | 2020 | 244371 | 0.08 | Why? |
| Medical Staff, Hospital | 1 | 2017 | 1258 | 0.08 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.08 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.08 | Why? |
| Humans | 32 | 2021 | 930598 | 0.08 | Why? |
| Nitriles | 1 | 2011 | 1053 | 0.08 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.08 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.08 | Why? |
| Biological Products | 1 | 2021 | 2331 | 0.08 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.08 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.07 | Why? |
| Practice Guidelines as Topic | 3 | 2018 | 15421 | 0.07 | Why? |
| Body Composition | 2 | 2018 | 414 | 0.07 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.07 | Why? |
| Workplace | 1 | 2016 | 2075 | 0.06 | Why? |
| Male | 14 | 2021 | 367725 | 0.06 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.06 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.06 | Why? |
| Muscle, Skeletal | 2 | 2018 | 915 | 0.05 | Why? |
| Female | 18 | 2021 | 380317 | 0.05 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.05 | Why? |
| Aged | 5 | 2020 | 215776 | 0.05 | Why? |
| Lipids | 2 | 2017 | 1079 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.05 | Why? |
| Pulmonary Surfactants | 1 | 2021 | 128 | 0.05 | Why? |
| Immunocompetence | 1 | 2020 | 280 | 0.05 | Why? |
| Infertility, Female | 3 | 1995 | 150 | 0.05 | Why? |
| Clindamycin | 1 | 1998 | 59 | 0.05 | Why? |
| Diet, Fat-Restricted | 1 | 2017 | 15 | 0.05 | Why? |
| Gentamicins | 1 | 1998 | 76 | 0.04 | Why? |
| Nuts | 1 | 2017 | 22 | 0.04 | Why? |
| Diet, Carbohydrate-Restricted | 1 | 2017 | 36 | 0.04 | Why? |
| Body Fat Distribution | 1 | 2017 | 25 | 0.04 | Why? |
| Thinness | 1 | 2018 | 99 | 0.04 | Why? |
| Nutritionists | 1 | 2018 | 82 | 0.04 | Why? |
| Therapeutic Irrigation | 1 | 1998 | 167 | 0.04 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.04 | Why? |
| Waist Circumference | 1 | 2017 | 199 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Menstruation Disturbances | 1 | 1995 | 19 | 0.04 | Why? |
| Oximetry | 1 | 2021 | 658 | 0.04 | Why? |
| Obesity, Abdominal | 1 | 2017 | 167 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.04 | Why? |
| Immune Tolerance | 1 | 2020 | 608 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Postoperative Period | 1 | 2017 | 651 | 0.04 | Why? |
| Life Style | 2 | 2018 | 2708 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Prognosis | 4 | 2020 | 32490 | 0.03 | Why? |
| Pregnancy Outcome | 1 | 1988 | 3803 | 0.03 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.03 | Why? |
| Nutrition Therapy | 1 | 2018 | 285 | 0.03 | Why? |
| Cholesterol, HDL | 1 | 2017 | 439 | 0.03 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.03 | Why? |
| Remission Induction | 1 | 2017 | 950 | 0.03 | Why? |
| Infertility, Male | 1 | 1998 | 322 | 0.03 | Why? |
| Tetany | 1 | 1992 | 3 | 0.03 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.03 | Why? |
| Cholesterol, LDL | 1 | 2017 | 499 | 0.03 | Why? |
| Europe | 2 | 2021 | 12702 | 0.03 | Why? |
| Enema | 1 | 1992 | 42 | 0.03 | Why? |
| Diet, Mediterranean | 1 | 2017 | 351 | 0.03 | Why? |
| Drug Monitoring | 1 | 2021 | 1408 | 0.03 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.03 | Why? |
| Phosphates | 1 | 1992 | 135 | 0.03 | Why? |
| Embryo Transfer | 2 | 1989 | 91 | 0.03 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.03 | Why? |
| Checklist | 1 | 2017 | 714 | 0.03 | Why? |
| Belgium | 1 | 2017 | 2064 | 0.03 | Why? |
| Metabolic Syndrome | 1 | 2018 | 810 | 0.03 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
| Program Evaluation | 1 | 2017 | 1929 | 0.02 | Why? |
| Exercise Therapy | 1 | 2017 | 976 | 0.02 | Why? |
| Fallopian Tube Diseases | 1 | 1987 | 3 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Congresses as Topic | 1 | 2017 | 1347 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Registries | 2 | 2017 | 12327 | 0.02 | Why? |
| Ovary | 1 | 1987 | 133 | 0.02 | Why? |
| Polycystic Ovary Syndrome | 1 | 1989 | 151 | 0.02 | Why? |
| Frailty | 1 | 2018 | 1432 | 0.02 | Why? |
| Urination Disorders | 1 | 1985 | 10 | 0.02 | Why? |
| Diet | 1 | 2018 | 2052 | 0.02 | Why? |
| Splenic Diseases | 1 | 1985 | 28 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.02 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.02 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Smoking | 1 | 2016 | 3358 | 0.02 | Why? |
| Health Promotion | 1 | 2016 | 2020 | 0.02 | Why? |
| Pregnancy | 3 | 2017 | 23879 | 0.01 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.01 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 5002 | 0.01 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 1995 | 1969 | 0.01 | Why? |
| France | 1 | 2017 | 12074 | 0.01 | Why? |
| Spleen | 1 | 1985 | 877 | 0.01 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.01 | Why? |
| Puberty, Delayed | 1 | 1995 | 3 | 0.01 | Why? |
| Amenorrhea | 1 | 1995 | 10 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Menarche | 1 | 1995 | 21 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 1998 | 10083 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Hypertension | 1 | 2016 | 8895 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Calcium Gluconate | 1 | 1992 | 9 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Constipation | 1 | 1992 | 99 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
| China | 1 | 2018 | 50654 | 0.01 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.01 | Why? |
| Triptorelin Pamoate | 1 | 1989 | 7 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Gonadotropin-Releasing Hormone | 1 | 1989 | 53 | 0.01 | Why? |
| Ovulation Induction | 1 | 1989 | 58 | 0.01 | Why? |
| Tissue Adhesions | 1 | 1987 | 33 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
| Calcium | 1 | 1992 | 708 | 0.01 | Why? |
| Age Factors | 1 | 1988 | 21039 | 0.01 | Why? |
| Torsion Abnormality | 1 | 1985 | 20 | 0.00 | Why? |
| Child | 1 | 1995 | 70012 | 0.00 | Why? |
Dicker's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(200)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(122)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_